95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.32%
EBIT growth below 50% of NEM's 75.50%. Michael Burry would suspect deeper competitive or cost structure issues.
21.32%
Operating income growth under 50% of NEM's 75.50%. Michael Burry would be concerned about deeper cost or sales issues.
-498.04%
Negative net income growth while NEM stands at 248.65%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-498.20%
Negative EPS growth while NEM is at 262.50%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-498.20%
Negative diluted EPS growth while NEM is at 262.50%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1345.03%
OCF growth above 1.5x NEM's 69.56%. David Dodd would confirm a clear edge in underlying cash generation.
1345.03%
FCF growth above 1.5x NEM's 346.88%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-100.00%
Negative 10Y revenue/share CAGR while NEM stands at 44.14%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-100.00%
Negative 5Y CAGR while NEM stands at 35.68%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Negative 3Y CAGR while NEM stands at 21.14%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3333.85%
3Y OCF/share CAGR above 1.5x NEM's 64.24%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1740.38%
Negative 3Y CAGR while NEM is 204.11%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
8252.36%
10Y equity/share CAGR above 1.5x NEM's 122.74%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
8252.36%
5Y equity/share CAGR above 1.5x NEM's 108.10%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
8577.55%
3Y equity/share CAGR above 1.5x NEM's 132.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3578.51%
AR growth well above NEM's 34.41%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
17000.92%
Positive asset growth while NEM is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
16152.91%
BV/share growth above 1.5x NEM's 7.29%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.32%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.